142 related articles for article (PubMed ID: 12669106)
21. Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors?
Zannad F
Drugs; 1993; 46 Suppl 2():172-81; discussion 182. PubMed ID: 7512472
[TBL] [Abstract][Full Text] [Related]
22. Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction.
Weber S; Vaur L; Ounnoughene Z; Schwob J; Dubroca I; Normand J; Etienne S; Charbonnier B
Am Heart J; 2002 Feb; 143(2):313-8. PubMed ID: 11835037
[TBL] [Abstract][Full Text] [Related]
23. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF
J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
[TBL] [Abstract][Full Text] [Related]
24. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic profile of trandolapril, a new angiotensin-converting enzyme inhibitor.
Conen H; Brunner HR
Am Heart J; 1993 May; 125(5 Pt 2):1525-31. PubMed ID: 8480624
[TBL] [Abstract][Full Text] [Related]
26. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
27. Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Bjergaard OP
Am Heart J; 1997 Aug; 134(2 Pt 2):S48-52. PubMed ID: 9313623
[TBL] [Abstract][Full Text] [Related]
28. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.
Richer C; Mulder P; Fornes P; Domergue V; Heudes D; Giudicelli JF
J Cardiovasc Pharmacol; 1992 Jul; 20(1):147-56. PubMed ID: 1383624
[TBL] [Abstract][Full Text] [Related]
30. Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor.
Duc LN; Brunner HR
Am J Cardiol; 1992 Oct; 70(12):27D-34D. PubMed ID: 1414922
[TBL] [Abstract][Full Text] [Related]
31. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension.
Wiseman LR; McTavish D
Drugs; 1994 Jul; 48(1):71-90. PubMed ID: 7525196
[TBL] [Abstract][Full Text] [Related]
32. Vascular affinity of trandolapril.
Miyazaki M; Kawamoto T; Okunishi H
Am J Hypertens; 1995 Oct; 8(10 Pt 2):63S-67S. PubMed ID: 8845086
[TBL] [Abstract][Full Text] [Related]
33. [The significance of trandelapril for mortality after AMI in patients with reduced left ventricular function. TRACE Study Group].
Køber L; Torp-Pedersen CT; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J
Ugeskr Laeger; 1997 Mar; 159(11):1616-22. PubMed ID: 9092145
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia.
Balling L; Kober L; Schou M; Torp-Pedersen C; Gustafsson F
J Card Fail; 2013 Nov; 19(11):725-30. PubMed ID: 24263115
[TBL] [Abstract][Full Text] [Related]
36. Trandolapril in patients with left ventricular dysfunction after myocardial infarction.
Neumayr G; Gänzer J
N Engl J Med; 1996 Jun; 334(23):1546. PubMed ID: 8618619
[No Abstract] [Full Text] [Related]
37. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
Messerli F; Frishman WH; Elliott WJ
Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
[TBL] [Abstract][Full Text] [Related]
38. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril.
Toga W; Tanonaka K; Takeo S
Biol Pharm Bull; 2007 Jan; 30(1):105-10. PubMed ID: 17202668
[TBL] [Abstract][Full Text] [Related]
39. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
